BCAT2 and familial pancreatic carcinoma: However, targeted drugs for BCAT2 are still lacking, the tracing of the diets of pancreatic cancer patients at an early stage still needs further study, and direct evidence to prove that dietary BCAA promotes PDAC progression in vivo needs to be addressed.